Filtros de búsqueda

Lista de obras de Dennis Slamon

Adjuvant trastuzumab in HER2-positive breast cancer

artículo científico publicado en 2011

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

artículo científico publicado en 2010

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients

artículo científico publicado en 2012

Concise total syntheses of (–)-jorunnamycin A and (–)-jorumycin enabled by asymmetric catalysis

artículo científico publicado en 2018

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer

artículo científico publicado en 2011

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

artículo científico publicado en 2013

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study

scientific article published on 28 June 2013

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

artículo científico publicado en 2010

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

artículo científico publicado en 2015

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

artículo científico publicado en 2020

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer

artículo científico publicado en 2014

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response

artículo científico publicado en 2021

The role of genetic breast cancer susceptibility variants as prognostic factors

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda